| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |